When Ozempic And Wegovy Fail To Work- Why GLP-1 Drugs Aren’t The Magic Bullet For Everyone
Ozempic and Wegovy have received a lot of publicity as revolutionizing treatment options for obesity. Both medications form a class of GLP-1 receptor agonists, which mimic a hormone in the body called glucagon-like peptide-1 and are involved in the regulation of appetite and blood sugar. Indeed, in initial clinical studies, the majority of those on the drugs lost 15% to 22% of body weight, hence much optimism. For most patients, these medications are underwhelming for about 20% of patients due to minimal weight loss or other challenges.
Take a closer look at why the weight loss drugs may not work for everyone, together with what options exist when they don't deliver the expected outcomes.
While GLP-1 receptor agonists have produced phenomenal responses in a majority of patients, it remains a reality that these drugs work differently for different people. Here's why:
1. Genetic and Hormonal Variability
Weight loss medications interact with complex systems in the body that differ from person to person. Genetics, hormones, and individual brain responses to energy regulation play significant roles in determining how a person responds to drugs like Ozempic and Wegovy.
2. Underlying Medical Conditions
Other conditions, such as sleep apnea, may be prevalent and prevent or delay the achievement of weight loss goals. Prescription drugs like antidepressants, steroids, or contraceptives are other medications that can nullify weight loss medication benefits.
3. Unrealistic Expectations
Often, they come to these medications with enormous hopes; expecting the promised rapid and dramatic weight loss. Progress creates disappointment if it has not stalled. In patients who rigidly follow recommended lifestyle modifications, frustration and disappointment are most common.
For most patients, the effectiveness of GLP-1 receptor agonists is evident within a few weeks of treatment. Weight loss typically begins within a few weeks of initiating therapy and tends to increase with dosage. However, some patients respond very little, if at all, despite strict adherence to their regimen.
For nonresponders, this can feel like a dead end. However, understanding the unique complexities of obesity is essential. This condition stems from brain dysfunction, and the pathways that contribute to weight regulation differ among individuals.
When Ozempic or Wegovy doesn’t yield desired results, there are still many paths to explore:
For example, some patients who don't respond well to one GLP-1 receptor agonist might find success with another drug in the same class. Newer medications, such as Zepbound, target other hormone pathways and seem promising even for those not responsive to earlier drugs.
While there is much to say about newer drugs, older treatments can still be useful and work for some patients. One can also seek the help of a medical provider specializing in obesity treatments in order to identify the best alternatives.
Diet, exercise, sleep, and stress management continue to be integral components of any weight loss program. New changes may be small but can make an enormous difference in one's health and success.
It is a complex disorder, and most patients should receive a multidisciplinary treatment. Collaboration with an obesity-aware doctor may mean access to tailored treatment plans, ranging from psychological support all the way to metabolic testing, and many others.
For others, side effects like nausea, vomiting, or diarrhea hinder them from continuing with these drugs. These symptoms often reduce as the body becomes accustomed, but for some, they might be severe enough to stop treatment altogether. In those instances, alternative drugs or procedures become vital to find.
Another largely unexplored area relates to GLP-1 drugs' long-term effects on the brain's regulation of hunger and satiety. Although GLP-1 drugs suppress appetite and can lead to effective weight loss, emerging research suggests that they may also affect brain reward mechanisms, changing the way patients experience foods.
This aspect could prove of paramount significance in the future treatment of obesity. Perhaps GLP-1 receptor agonists do indeed affect and rewire the brain's reward pathways and will thus provide sustained benefits beyond discontinuation. However, more research is required to understand this phenomenon fully.
While for many, Ozempic and Wegovy have revolutionized obesity treatment, these are certainly not a one size fits all. Nonresponders need not lose hope- alternative strategies and medications abound. A consultation with an obesity expert healthcare provider is essential to put together a comprehensive, tailored treatment plan.
The route toward effective weight loss may be challenging, but with the evolution of obesity medicine and a better understanding of individual needs, there is a path forward for everyone.
Credit: Chantelle Broadley / SWNS
Ten-year-old Myla from the UK's North Yorkshire, with severe eye strain, was diagnosed with a severe brain tumor that led to her death.
The young girl had been suffering from headaches and dizziness, which were dismissed as mere eye strain due to playing on her iPad too much.
Thinking that she needed eyeglasses, her parents took her for an eye appointment, where she was diagnosed with an aggressive diffuse midline glioma — a type of brain tumor.
Myla was diagnosed with a 7-10cm tumor and was rushed to Sheffield Children's Hospital for an operation to remove 60 per cent of the mass. The youngster underwent a grueling 30 rounds of radiotherapy but tragically passed away on January 15, The Mirror.co.uk reported.
Healthandme spoke to health experts to understand the role of eye strain and brain tumors.
The health experts noted that although prolonged exposure to digital screens can raise the risk of vision problems, they cannot cause brain tumors.
"Eye strain is most commonly linked to prolonged screen use, poor ergonomics, or uncorrected vision, and in the vast majority of cases, it is not a sign of brain cancer," Dr. Parul Maheshwari Sharma, Ophthalmologist and Principal Director & HOD - at Fortis Gurugram, told HealthandMe.
"The likelihood of experiencing eye strain being an indication of brain cancer is minimal," added Dr. Mahipal Singh Sachdev, Chairman & Medical Director, Centre For Sight Group of Eye Hospitals.
The doctors explained that brain tumors are rarely present as simple eye strain; they are usually associated with additional symptoms such as:
Eye strain, also referred to as digital eye strain or computer vision syndrome, is caused by staring at screens for extended periods of time and decreased blinking.
It generally occurs due to benign factors such as excessive screen time, dry eye, or uncorrected vision.
While prolonged screen use can cause discomfort, dry eyes, and temporary blurred vision, it does not lead to the development of cancer.
"There is no evidence to suggest that screen-induced eye strain can cause brain tumors," Dr Sharma said.
"Although there may be visual changes due to a tumor that involves the optic nerve or hypothalamus, simple eye strain is not indicative of brain tumors and would not be considered an early warning of a brain tumor. There is an extremely low probability that eye strain will be due to a brain tumor," Dr. Sachdev told HealthandMe.
However, the experts agreed that long screen time can lead to severe eye strain.
Brain tumors are generally attributed to genetics, exposure to radiation, or other unknown factors.
Numerous types of red flags could indicate the presence of a serious neurological disorder. Some examples include
Higher-risk patients include:
To help combat eye fatigue, individuals can adopt some simple habits, such as
Dehydration can lead to poor concentration in women. (Photo credit: iStock)
Ladies, does it ever happen to you that you are not on your period, not PMSing, and still feel moody and upset? Well, as it turns out, experts say that there could be a very simple reason for this. According to researchers at the University of Connecticut, even mild dehydration could be responsible for mood changes in women. Not only this, even 1.36 per cent dehydration can affect your mood, ability to think and energy levels. The Daily Mail notes that a loss of 1.5 per cent of normal water volume levels in the body can be classified as mild dehydration, and its adverse effects can linger for some time.
Read more: The Health Problems Women Normalise, But Gynaecologists Do Not
In women, the adverse effects of dehydration can be serious. Experts say that the effects are more intense in women, and they came to this conclusion after analysing the results of tests, which revealed that it does not matter if a person walks for 40 minutes on a treadmill or is in a state of rest — if an individual is even slightly thirsty, the adverse effects will be the same.
Research shows that even 1.36 per cent dehydration is enough to cause the following problems:
Is thirst the same as dehydration?
Lead researcher of the study, Lawrence Armstrong, noted that a sensation of thirst does not appear until a person is one or two per cent dehydrated. By then, it starts to set in and act up, adversely impacting how the mind and body perform. Dehydration can affect everyone, which is why it is just as important for people in desk jobs to stay hydrated as it is for marathon runners.
Read more: Three Health Checks Every Woman Should Do Each Month, According To Experts
In this research, experts put participants through a series of tests evaluating their concentration, vigilance, reaction time, reasoning, memory and learning. The results were then compared with those of people who were not dehydrated. In younger women, mild dehydration resulted in fatigue, headaches and concentration difficulties. Women also found basic tasks more difficult to execute than usual. On the other hand, young men noted some difficulty in performing mental tasks — they experienced anxiety, fatigue and tension in the process. Mood changes were more prominent in women than in men.
The oral microbiome is the community of bacteria, fungi, and other microorganisms that naturally live in the mouth — on the teeth, gums, tongue, and cheeks. More than
700 species are known to exist, most of which are harmless and many beneficial.
However, problems arise when harmful bacteria outnumber protective ones, leading to gum inflammation or periodontal disease. During pregnancy, hormonal changes increase blood flow to the gums and alter immune responses. As a result, many women notice bleeding, swelling, or sensitivity in the gums — a condition known as pregnancy gingivitis.
This is common and reflects physiological changes rather than poor hygiene.
Pregnancy is a systemic state in which the immune system, circulation, and inflammation are closely interconnected. Chronic gum inflammation can release inflammatory mediators into the bloodstream.
In research settings, certain oral bacteria have also been detected in placental tissues from complicated pregnancies. This suggests a biological link between oral health and
placental function, although the exact pathways are still being studied.
Importantly, this relationship reflects association rather than direct causation.
The placenta is an active organ that regulates oxygen and nutrient transfer, hormone production, and immune protection for the developing baby.
Healthy placental development supports:
Up to 60–75 percent of pregnant women experience some degree of gum inflammation. Common changes include:
Research from India and globally shows associations between periodontal disease and higher risks of preterm birth, low birth weight, and preeclampsia. Meta-analyses
suggest a modest increase in risk (around 1.5–2 times).
However, pregnancy complications are multifactorial. Oral disease alone does not directly cause these outcomes. Genetics, nutrition, metabolic health, and placental
biology all play important roles.
Treating gum disease improves oral health and reduces inflammation, though studies show mixed evidence on whether it directly lowers preterm birth risk. The goal is
prevention, awareness, and overall maternal health.
Daily oral care:
Pregnancy already carries emotional and physical changes, and dental symptoms can add anxiety. Support from partners and family members helps reduce mental load.
Stress can influence immunity and inflammation. Adequate rest, gentle activity such as walking or prenatal yoga, and open communication with healthcare providers
support both oral and overall health.
Seek professional advice if you notice:
Pregnancy is a time when different systems of the body work in close coordination. Oral health, immune balance, and placental function are part of the same continuum.
Gentle attention to gum health is not about perfection. It is about creating supportive conditions for a healthy pregnancy and a healthy baby.
© 2024 Bennett, Coleman & Company Limited